Cargando…

ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA

1. Protective substances and agglutinins were not demonstrated in the blood of patients with pneumonia untreated with serum before the fall in the temperature by crisis or lysis. 2. Protective substances and agglutinins were frequently demonstrated in serum treated patients during the course of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lord, Frederick T., Nesche, George E.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1929
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131646/
https://www.ncbi.nlm.nih.gov/pubmed/19869638
_version_ 1782142279311425536
author Lord, Frederick T.
Nesche, George E.
author_facet Lord, Frederick T.
Nesche, George E.
author_sort Lord, Frederick T.
collection PubMed
description 1. Protective substances and agglutinins were not demonstrated in the blood of patients with pneumonia untreated with serum before the fall in the temperature by crisis or lysis. 2. Protective substances and agglutinins were frequently demonstrated in serum treated patients during the course of the disease. 3. Protective substances and agglutinins were usually present at the time of the temperature fall in patients untreated with serum and persisted for days or weeks thereafter. 4. Protective substances have an important bearing on the outcome. A large proportion of those with protection recover and a large proportion without it die. 5. Agglutinin and antibody may appear simultaneously or one may precede or be present without the other. 6. Tests for agglutinin are unreliable as a control of dosage of specific serum.
format Text
id pubmed-2131646
institution National Center for Biotechnology Information
language English
publishDate 1929
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21316462008-04-18 ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA Lord, Frederick T. Nesche, George E. J Exp Med Article 1. Protective substances and agglutinins were not demonstrated in the blood of patients with pneumonia untreated with serum before the fall in the temperature by crisis or lysis. 2. Protective substances and agglutinins were frequently demonstrated in serum treated patients during the course of the disease. 3. Protective substances and agglutinins were usually present at the time of the temperature fall in patients untreated with serum and persisted for days or weeks thereafter. 4. Protective substances have an important bearing on the outcome. A large proportion of those with protection recover and a large proportion without it die. 5. Agglutinin and antibody may appear simultaneously or one may precede or be present without the other. 6. Tests for agglutinin are unreliable as a control of dosage of specific serum. The Rockefeller University Press 1929-09-30 /pmc/articles/PMC2131646/ /pubmed/19869638 Text en Copyright © Copyright, 1929, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Lord, Frederick T.
Nesche, George E.
ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA
title ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA
title_full ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA
title_fullStr ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA
title_full_unstemmed ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA
title_short ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA
title_sort antibody and agglutinin in pneumococcus pneumonia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2131646/
https://www.ncbi.nlm.nih.gov/pubmed/19869638
work_keys_str_mv AT lordfrederickt antibodyandagglutinininpneumococcuspneumonia
AT neschegeorgee antibodyandagglutinininpneumococcuspneumonia